Suppliers / Ambio

Ambio

United States 19 employees Updated 9 July 2026

Ambio is an API manufacturer based in United States. It holds 6 active US drug master files across a filed portfolio of 6 molecules.

6
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Grovetown, United States 3010755363

What they file, and where

Molecule Regulators Docs
Glatiramer US FDA 1
Icatibant US FDA 1
Liraglutide US FDA 1
Semaglutide US FDA 1
Teduglutide US FDA 1
Teriparatide US FDA 1

Also appears on these molecule pages

Liraglutide API Semaglutide API

Filings and GMP by regulator

Regulator Filings GMP certificates
MPA (SE) 1 None

Comparing suppliers?

Choose your molecules and target markets. Ambio comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability